Fig. 2

Quarterly randomizations to extended-release buprenorphine and extended-release naltrexone in the New Hampshire EXIT-CJS study site: July 2021-December 2023
Quarterly randomizations to extended-release buprenorphine and extended-release naltrexone in the New Hampshire EXIT-CJS study site: July 2021-December 2023